查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1662015

狂犬病诊断全球市场报告 2025

Rabies Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年狂犬病诊断市场规模将出现强劲成长。到 2029 年，这一数字将成长至 23.1 亿美元，年复合成长率（CAGR）为 6.7%。预测期内的增长可归因于狂犬病发病率的增加、环境影响、成本效益、研究和开发以及监测需求。预测期内的主要趋势包括政府倡议和疫苗接种计划、全球化和旅行、「同一个健康」方法、公共卫生问题以及远距离诊断和照护现场诊断。

狂犬病发病率的上升预计将推动狂犬病诊断市场的成长。狂犬病是一种可预防的病毒性疾病，主要透过受感染动物咬伤而传播。狂犬病毒侵入哺乳动物的中枢神经系统，最终导致脑损伤和死亡。狂犬病诊断使用多种测试和技术来检测人类和动物中是否存在狂犬病毒。此外，动物传播感染疾病的增加也增加了狂犬病诊断的需求。例如，加拿大政府于 2023 年 1 月发布的一份报告发现，2022 年 10 月提交了 135 份狂犬病检体，11 月又提交了 159 份检体。因此，狂犬病患病率的上升预计将推动狂犬病诊断市场的发展。

都市化趋势预计将推动狂犬病诊断市场的成长。在经济成长和工业化的推动下，都市化正在将农村地区转变为城市中心。在这转变过程中，狂犬病诊断对于快速发现和管理人口密集的城市环境中的狂犬病疫情以及保护公众健康发挥着至关重要的作用。根据世界银行集团2023年4月发布的报告，目前全球一半以上的人口居住在都市区，预计到2045年这一数字将增加1.5倍，达到60亿。因此，快速的都市化正在成为推动狂犬病诊断市场发展的催化剂。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球狂犬病诊断PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球狂犬病诊断市场：成长率分析
  • 全球狂犬病诊断市场表现：规模与成长，2019 年至 2024 年
  • 全球狂犬病诊断市场预测：2024-2029 年、2034 年规模与成长
  • 全球狂犬病诊断总目标市场 (TAM)

第六章 市场细分

  • 全球狂犬病诊断市场：按诊断方法、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 萤光抗体检测
  • 免疫组织化学
  • 扩增方法
  • 组织学检查
  • 血清检测
  • 全球狂犬病诊断市场（依技术、绩效与预测），2019-2024 年、2024-2029 年、2034 年
  • ELISA 或免疫组织化学
  • 层析法技术
  • PCR
  • 其他技术
  • 全球狂犬病诊断市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 癌症安宁疗护门诊
  • 其他最终用户
  • 全球狂犬病诊断市场：萤光抗体检测细分市场、类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接萤光抗体检测（DFA）
  • 全球狂犬病诊断市场：免疫组织化学细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）
  • 蛋白质印迹法
  • 全球狂犬病诊断市场：按扩增方法细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 逆转录 PCR（RT-PCR）
  • 全球狂犬病诊断市场：组织学检测细分、类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 显微镜
  • 组织染色技术
  • 全球狂犬病诊断市场：血清学细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 病毒中和测试 (VNT)
  • 酵素免疫分析法（ELISA）

第七章 区域和国家分析

  • 全球狂犬病诊断市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球狂犬病诊断市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 狂犬病诊断市场：竞争格局
  • 狂犬病诊断市场：公司简介
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • The Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • Aviva Systems Biology Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Creative Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Demeditec Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Abbexa Ltd.
  • Norgen Biotek Corp.
  • BioNote Inc.
  • Express Biotech International Inc.
  • MyBioSource Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies Inc.
  • Fluidigm Corp.
  • Bio-X Diagnostics SA
  • Fujirebio Diagnostics Inc.
  • Gold Standard Diagnostics Corp.
  • Heska Corporation
  • IDEXX Laboratories Inc.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 狂犬病诊断市场 2029：提供新机会的国家
  • 狂犬病诊断市场 2029：细分市场提供新机会
  • 狂犬病诊断市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r22900

Rabies diagnostics involve identifying the Rabies disease based on observed conditions and symptoms. This preventable viral illness is commonly transmitted through the bite of a rabid animal. Diagnosis of Rabies typically involves locating the rabies virus within any part of the infected animal's brain. In humans, diagnosis includes testing saliva, serum, spinal fluid, and skin biopsies from hair follicles at the back of the neck.

The methods employed in Rabies diagnostics encompass various tests such as fluorescent antibody tests, immunohistochemical tests, amplification methods, histologic examinations, and serology tests. The fluorescent antibody test (FA) is based on detecting rabies virus proteins (antigen) in the tissues of infected animals. Technologies utilized include ELISA/immunohistochemistry, chromatography techniques, PCR, and others. These diagnostics are commonly employed by hospitals, diagnostic centers, cancer palliative care clinics, and diverse end-users, including pharmacies.

The rabies diagnostics market research report is one of a series of new reports from The Business Research Company that provides rabies diagnostics market statistics, including rabies diagnostics industry global market size, regional shares, competitors with a rabies diagnostics market share, detailed rabies diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rabies diagnostics industry. This rabies diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.68 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to globalization and travel patterns, one health approach adoption, regulatory standards development, advancements in animal testing, environmental influences.

The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing rabies incidence, environmental impact, cost efficiency, research and development, surveillance needs. Major trends in the forecast period include government initiatives and vaccination programs, globalization and travel, one health approach, public health concerns, remote and point-of-care diagnostics.

The rising incidence of rabies is anticipated to drive the growth of the rabies diagnostics market. Rabies is a preventable viral disease primarily transmitted through the bite of an infected animal. The rabies virus affects the central nervous systems of mammals, ultimately leading to brain damage and death. Rabies diagnostics involve various tests and techniques to detect the presence of the rabies virus in both humans and animals. Furthermore, the increasing number of cases of infectious diseases transmitted by animals has heightened the demand for rabies diagnostics. For example, a report from the Government of Canada, published in January 2023, indicated that 135 rabies samples were submitted in October 2022, followed by 159 samples in November 2022. Consequently, the growing prevalence of rabies is expected to boost the rabies diagnostics market.

The ongoing trend of urbanization is anticipated to fuel the growth of the rabies diagnostics market. Urbanization, driven by economic growth and industrialization, transforms rural areas into urban hubs. In this transition, rabies diagnostics play a pivotal role in swiftly detecting and managing rabies outbreaks within densely populated urban settings, safeguarding public health. As per an April 2023 report by the World Bank Group, over half of the global population currently resides in urban areas, a figure projected to climb to 6 billion by 2045, marking a 1.5-fold increase. Consequently, the surging urbanization serves as a catalyst propelling the rabies diagnostics market forward.

The growing emphasis on research and development (R&D) activities is expected to boost the rabies diagnostics market. R&D encompasses the systematic investigation, experimentation, and innovation aimed at creating new products, enhancing existing ones, or developing new technologies and methodologies. The rise in R&D activities is attributed to various factors, including heightened awareness of diseases, increased public and private investments, and health initiatives. These activities contribute to advancements in rabies diagnostics by identifying novel biomarkers and testing methods that improve sensitivity and specificity. This progress facilitates the development of rapid, cost-effective tests for the timely detection of the virus in clinical samples. For instance, in December 2023, Eurostat, the statistical office of the European Union based in Luxembourg, reported that the EU's R&D expenditure reached €352 billion ($384.42 billion) in 2022, reflecting a 6.34% increase from €331 billion ($361.48 billion) the previous year. Thus, the escalation of research and development activities is likely to drive growth in the rabies diagnostics market.

Product innovation stands as a prominent trend shaping the rabies diagnostics market. Pharmaceutical manufacturers globally are focusing on developing sophisticated testing techniques within analytical chemistry to deliver precise and cost-effective analytical solutions. These testing products seamlessly integrate into routine sample testing processes. For instance, in May 2022, Bio-Rad Laboratories Inc., a US-based technology developer, unveiled the CFX Duet Real-Time PCR system. This clinical diagnostic device aids researchers in creating singleplex and duplex quantitative PCR (qPCR) tests, boasting enhanced thermal performance, a patented optical shuttle system, and thermal gradient functionality for optimization.

Leading companies in the rabies diagnostics market are focused on developing innovative products, such as rabies antibody test kits, to maintain their competitive edge. A rabies antibody test kit is a diagnostic tool that detects antibodies in the blood to evaluate immunity levels or determine the need for additional rabies vaccinations. For example, in February 2024, BioStone Animal Health, a US-based diagnostic company, introduced AsurDx. This rabies antibody test kit utilizes a rapid and sensitive ELISA method to identify antibodies specific to the rabies virus in mammalian serum samples. It offers a cost-effective solution for assessing rabies immunity, making it suitable for both vaccinated animals and those at risk. Designed for ease of use, the kit provides reliable results, helping ensure that animals meet the standard of 0.5 international units (UL) per ml for effective immune response against rabies.

Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation, Virbac Animal health Pvt. Ltd., Zoetis Inc.

North America was the largest region in the rabies diagnostics market in 2024. The regions covered in the rabies diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rabies diagnostics market includes revenues earned by entities by providing diagnostic services such as reverse transcription followed by polymerase chain reaction (RT-PCR), virus isolation, and direct fluorescent antibody (DFA) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rabies Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rabies diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rabies diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rabies diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Method: Fluorescent Antibody Test; Immunohistochemical Test; Amplification Methods; Histologic Examination; Serology Tests
  • 2) By Technology: ELISA Or Immunohistochemistry; Chromatography Techniques; PCR; Other Technologies
  • 3) By End-User: Hospital; Diagnostic Centers; Cancer Palliative Care Clinics; Other End-Users
  • Subsegments:
  • 1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
  • 2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA): Western Blotting
  • 3) By Amplification Methods: Polymerase Chain Reaction (PCR); Reverse Transcription PCR (RT-PCR)
  • 4) By Histologic Examination: Microscopic Examination; Tissue Staining Techniques
  • 5) By Serology Tests: Virus Neutralization Test (VNT); Enzyme-Linked Immunosorbent Assay (ELISA)
  • Companies Mentioned: Bio-Rad Laboratories Inc.; The Merck Group; Aviva Systems Biology Corporation; Creative Diagnostics; Demeditec Diagnostics GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rabies Diagnostics Market Characteristics

3. Rabies Diagnostics Market Trends And Strategies

4. Rabies Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Rabies Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Rabies Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Rabies Diagnostics Market Growth Rate Analysis
  • 5.4. Global Rabies Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Rabies Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Rabies Diagnostics Total Addressable Market (TAM)

6. Rabies Diagnostics Market Segmentation

  • 6.1. Global Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescent Antibody Test
  • Immunohistochemical Test
  • Amplification Methods
  • Histologic Examination
  • Serology Tests
  • 6.2. Global Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ELISA Or Immunohistochemistry
  • Chromatography Techniques
  • PCR
  • Other Technologies
  • 6.3. Global Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Diagnostic Centres
  • Cancer Palliative Care Clinics
  • Other End-Users
  • 6.4. Global Rabies Diagnostics Market, Sub-Segmentation Of Fluorescent Antibody Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Fluorescent Antibody Test (DFA)
  • 6.5. Global Rabies Diagnostics Market, Sub-Segmentation Of Immunohistochemical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blotting
  • 6.6. Global Rabies Diagnostics Market, Sub-Segmentation Of Amplification Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Reverse Transcription PCR (RT-PCR)
  • 6.7. Global Rabies Diagnostics Market, Sub-Segmentation Of Histologic Examination, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microscopic Examination
  • Tissue Staining Techniques
  • 6.8. Global Rabies Diagnostics Market, Sub-Segmentation Of Serology Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Virus Neutralization Test (VNT)
  • Enzyme-Linked Immunosorbent Assay (ELISA)

7. Rabies Diagnostics Market Regional And Country Analysis

  • 7.1. Global Rabies Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Rabies Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rabies Diagnostics Market

  • 8.1. Asia-Pacific Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rabies Diagnostics Market

  • 9.1. China Rabies Diagnostics Market Overview
  • 9.2. China Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rabies Diagnostics Market

  • 10.1. India Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rabies Diagnostics Market

  • 11.1. Japan Rabies Diagnostics Market Overview
  • 11.2. Japan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rabies Diagnostics Market

  • 12.1. Australia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rabies Diagnostics Market

  • 13.1. Indonesia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rabies Diagnostics Market

  • 14.1. South Korea Rabies Diagnostics Market Overview
  • 14.2. South Korea Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rabies Diagnostics Market

  • 15.1. Western Europe Rabies Diagnostics Market Overview
  • 15.2. Western Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rabies Diagnostics Market

  • 16.1. UK Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rabies Diagnostics Market

  • 17.1. Germany Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rabies Diagnostics Market

  • 18.1. France Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rabies Diagnostics Market

  • 19.1. Italy Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rabies Diagnostics Market

  • 20.1. Spain Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rabies Diagnostics Market

  • 21.1. Eastern Europe Rabies Diagnostics Market Overview
  • 21.2. Eastern Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rabies Diagnostics Market

  • 22.1. Russia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rabies Diagnostics Market

  • 23.1. North America Rabies Diagnostics Market Overview
  • 23.2. North America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rabies Diagnostics Market

  • 24.1. USA Rabies Diagnostics Market Overview
  • 24.2. USA Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rabies Diagnostics Market

  • 25.1. Canada Rabies Diagnostics Market Overview
  • 25.2. Canada Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rabies Diagnostics Market

  • 26.1. South America Rabies Diagnostics Market Overview
  • 26.2. South America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rabies Diagnostics Market

  • 27.1. Brazil Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rabies Diagnostics Market

  • 28.1. Middle East Rabies Diagnostics Market Overview
  • 28.2. Middle East Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rabies Diagnostics Market

  • 29.1. Africa Rabies Diagnostics Market Overview
  • 29.2. Africa Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rabies Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Rabies Diagnostics Market Competitive Landscape
  • 30.2. Rabies Diagnostics Market Company Profiles
    • 30.2.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Aviva Systems Biology Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Creative Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Demeditec Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Rabies Diagnostics Market Other Major And Innovative Companies

  • 31.1. Abbexa Ltd.
  • 31.2. Norgen Biotek Corp.
  • 31.3. BioNote Inc.
  • 31.4. Express Biotech International Inc.
  • 31.5. MyBioSource Inc.
  • 31.6. QIAGEN N.V.
  • 31.7. Thermo Fisher Scientific Inc.
  • 31.8. F. Hoffmann-La Roche Ltd.
  • 31.9. Agilent Technologies Inc.
  • 31.10. Fluidigm Corp.
  • 31.11. Bio-X Diagnostics S.A.
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Gold Standard Diagnostics Corp.
  • 31.14. Heska Corporation
  • 31.15. IDEXX Laboratories Inc.

32. Global Rabies Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rabies Diagnostics Market

34. Recent Developments In The Rabies Diagnostics Market

35. Rabies Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Rabies Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Rabies Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Rabies Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer